[go: up one dir, main page]

UY27206A1 - METHOD OF TREATMENT OF CONDITIONS OR DEMELINIZING DISEASES - Google Patents

METHOD OF TREATMENT OF CONDITIONS OR DEMELINIZING DISEASES

Info

Publication number
UY27206A1
UY27206A1 UY27206A UY27206A UY27206A1 UY 27206 A1 UY27206 A1 UY 27206A1 UY 27206 A UY27206 A UY 27206A UY 27206 A UY27206 A UY 27206A UY 27206 A1 UY27206 A1 UY 27206A1
Authority
UY
Uruguay
Prior art keywords
treatment
diseases
conditions
demelinizing
vasculocerebral
Prior art date
Application number
UY27206A
Other languages
Spanish (es)
Inventor
Craig P Smith
Michel P Rathbone
Margaret Petty
David Rampe
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Priority to UY27206A priority Critical patent/UY27206A1/en
Publication of UY27206A1 publication Critical patent/UY27206A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

N-(Piridinil)-1H-indól-1-aminas de fórmula (I) proveen una singular combinación de propiedades de bloqueo tanto de los canales de potasio como los de sodio. Estos compuestos son útiles para el tratamiento de condiciones y enfermedades desmielinizantes tales como esclerosis múltiple, lesiones de la médula espinal, lesiones traumáticas del cerebro y accidentes vásculocerebrales. Los compuestos son útiles para la rehabilitación de los accidentes vásculocerebrales, para el tratamiento de disfunción e irritación de la vejiga, y para el tratamiento de dolores neuropáticos y dolores inducidos por quimosina.N- (Pyridinyl) -1H-indole-1-amines of formula (I) provide a unique combination of blocking properties of both potassium and sodium channels. These compounds are useful for the treatment of demyelinating conditions and diseases such as multiple sclerosis, spinal cord injuries, traumatic brain injuries and vasculocerebral accidents. The compounds are useful for the rehabilitation of vasculocerebral accidents, for the treatment of bladder dysfunction and irritation, and for the treatment of neuropathic pain and chymosin-induced pain.

UY27206A 2002-03-13 2002-03-13 METHOD OF TREATMENT OF CONDITIONS OR DEMELINIZING DISEASES UY27206A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27206A UY27206A1 (en) 2002-03-13 2002-03-13 METHOD OF TREATMENT OF CONDITIONS OR DEMELINIZING DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27206A UY27206A1 (en) 2002-03-13 2002-03-13 METHOD OF TREATMENT OF CONDITIONS OR DEMELINIZING DISEASES

Publications (1)

Publication Number Publication Date
UY27206A1 true UY27206A1 (en) 2002-07-31

Family

ID=38812602

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27206A UY27206A1 (en) 2002-03-13 2002-03-13 METHOD OF TREATMENT OF CONDITIONS OR DEMELINIZING DISEASES

Country Status (1)

Country Link
UY (1) UY27206A1 (en)

Similar Documents

Publication Publication Date Title
ECSP024218A (en) METHOD OF TREATMENT OF DISEASES OR CONDITIONS
PL414996A1 (en) Application of 40-O-(2-hydroxyethyl)-rapamycin for manufacturing the medicine for treatment of solid tumors in the central nervous system
ECSP034809A (en) CICLOBUTENO-1,2-DIONAS 3,4-DISUSTITUTED AS LIGANDS OF THE CXC CHEMOCINE RECEIVER
ECSP066355A (en) COMPOUNDS OF 2- (QUINOXALIN-5-ILSULPHONYLAMINE) -BENZAMIDE AS MODULATORS OF COLECISTOCININE 2
ECSP034810A (en) DERETADOS HETEROCICLILALCOXI-, -ALQUILTIO- Y - ALQUILAMINOBENZAZOL SUCH AS LIGANDOS 5-HIDROXITRIPTAMINA-6
BRPI0415179A (en) amide derivatives such as ion channel ligands and pharmaceutical compositions and methods of employing them
HK1051499A1 (en) Method for treating ocular pain
BRPI0418181A (en) use of substituted 2-aminotetralines to prevent treatment of morbus parkinson
CR7195A (en) NEW DERIVATIVES OF OXAZOLIDINONES AS ANTIBACTERIALS
MXPA05011233A (en) Somatostatin vectors.
ITMI20030573A1 (en) NOOTROPIC ACTION COMPOUNDS, THEIR PREPARATION,
DE60325377D1 (en) MOTILIDVERBINDUNGEN
CY1107562T1 (en) USE OF N- (2-Aryl-Propionyl) -suclfonamides for the treatment of traumatic brain injury
GB0207653D0 (en) Methods of using lamellar bodies for therapeutic purposes
PL372769A1 (en) Cyanoguanidine prodrugs
UY27206A1 (en) METHOD OF TREATMENT OF CONDITIONS OR DEMELINIZING DISEASES
IL166627A0 (en) Treatment of multiple sclerosis with brain targeted anti-oxidant compounds
DE602004024871D1 (en) POLYAMINE COMPOUNDS FOR THE TREATMENT OF CHEMOKIN RECEPTOR-MEDIATED DISEASES
ES1050463Y (en) THERAPEUTIC DEVICE FOR THE TREATMENT OF SYMPTOMS CAUSED BY DISEASES.
EA200200750A1 (en) NEW THERAPEUTIC APPLICATION OF ENOXAPARIN
GT199800033A (en) ARISULFONAMIDES AND ANALOGS.
UY26641A1 (en) ARIL- AND HETEROARILSULFONATOS
UY27768A1 (en) 2- (2,6- DICLOROPHENIL) -DIARILIMIDAZOLES
UA6623U (en) Method for increasing therapeutic efficacy of clays
GT200400196A (en) ANTIBACTERIAL MACROCICLIC AMIDES

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20111121